Protecting pediatric oncology patients from influenza.
Influenza is a common respiratory pathogen. Its severity can be unpredictable, but people with chronic illness are at increased risk of severe infection, complications, and death from influenza. This review examines evidence to support various strategies to protect pediatric oncology patients from influenza-related morbidity. Influenza vaccination should be considered standard. Additional evidence-supported measures include antiviral treatment, antiviral prophylaxis, cohorting of patients, and hospital infection control measures. Data from other high-risk populations support the vaccination of family members, double-dose or high-dose vaccination, and the use of barrier methods. These measures have the potential to optimize patient outcomes because there will be fewer treatment interruptions for acute illness. These strategies can also protect patients from prolonged hospitalizations and morbidity related to influenza.
Division of Oncology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Pennsylvania, USA.
Leslie S
LS
Kersun
Anne F
AF
Reilly
Susan E
SE
Coffin
Kathleen E
KE
Sullivan
D002648:Child; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D009369:Neoplasms / Q000821:virology*; D012307:Risk Factors; D014611:Vaccination / Q000379:methods*
D007252:Influenza Vaccines